Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2015 | Can we afford to have CLL patients on a therapy for the rest of their lives?

At the American Society of Hematology (ASH) 2015 Annual Meeting, John Gribben, MD, DSc and Stephan Stilgenbauer, MD discuss the challenges of long-term therapy in chronic lymphocytic leukemia (CLL) patients.